Movicol Junior Choklad

Macrogol 3350, the active ingredient in Movicol Junior Choklad, is an osmotic laxative presented as an oral solution for oral use. It treats constipation, fecal impaction and aids bowel preparation in pediatric patients.

GNH USA supplies Movicol Junior Choklad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to healthcare providers across multiple regions. Its global distribution network ensures timely delivery and reliable supply chain management for essential medicines.

Movicol Junior Choklad, an osmotic laxative, is indicated for conditions affecting bowel transit and stool consistency.

Constipation: softens the stool by retaining water in the intestinal lumen, thereby promoting regular and comfortable bowel movements in children. Fecal impaction: helps to hydrate and soften hardened stool masses, facilitating their breakdown and safe evacuation without the need for invasive procedures. Bowel preparation: clears the intestinal tract by increasing stool fluidity, providing an effective non‑invasive preparation for diagnostic examinations in pediatric patients.

Macrogol 3350 may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: a feeling of fullness in the abdomen. - Nausea: mild queasiness that may occur after dosing. - Flatulence: increased intestinal gas leading to discomfort. - Mild abdominal pain: transient cramping without severe intensity.

Serious or Rare Side Effects: - Severe electrolyte imbalance: significant changes in sodium or potassium levels. - Severe dehydration: excessive fluid loss requiring medical attention. - Allergic reaction such as rash or angioedema: signs of hypersensitivity that need prompt evaluation.

Before initiating therapy, consider the following safety measures.

Assess hydration status: ensure the child is adequately hydrated before starting treatment. Monitor electrolytes: regular checks of sodium and potassium levels are recommended during prolonged use. Medical supervision: use under the guidance of a healthcare professional, especially in pediatric patients. Avoid in intestinal obstruction: contraindicated when a mechanical blockage is present. Dose adjustment in renal impairment: reduce dose or increase monitoring in patients with reduced kidney function. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Review potential drug interactions prior to prescribing.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: may cause excessive fluid loss and electrolyte disturbances. - High-dose potassium supplements: risk of hyperkalemia when combined with the potassium chloride component. - Loop diuretics: can exacerbate electrolyte imbalance.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment when combined with fluid shifts. - ACE inhibitors: monitor blood pressure and renal function due to potential additive effects on electrolytes. - Antacids containing magnesium or aluminum: may affect absorption of electrolytes.